CE: Celanese Corporation Stock

by  •  • Comments Off on CE: Celanese Corporation Stock

SIC 282 – Plastics Materials And Synthetic Resins, Synthetic

Valuation
Market Cap ($M) 17,284.52
Enterprise Value ($M) 30,625.52
Book Value ($M) 7,552.00
Book Value / Share 67.69
Price / Book 2.29
NCAV ($M) -12,827.00
NCAV / Share -114.97
Price / NCAV -1.35

Profitability (mra)
Return on Invested Capital (ROIC) 0.09
Return on Assets (ROA) 0.08
Return on Equity (ROE) 0.32

Liquidity (mrq)
Quick Ratio 0.95
Current Ratio 1.53

Balance Sheet (mrq) ($M)
Current Assets 6,218.00
Assets 26,597.00
Liabilities 19,045.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 10,940.00
Operating Income 1,087.00
Net Income 1,960.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 1,899.00
Cash from Investing -134.00
Cash from Financing -1,456.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Berkshire Hathaway Inc 0.00 -100.00
02-13 13G/A Vanguard Group Inc 12.01 -1.92
02-13 13G/A Dodge & Cox 6.30 -3.66
02-09 13G/A Capital Research Global Investors 13.60 4.33
02-09 13G/A Wellington Management Group Llp 7.84 22.51
02-09 13G Capital World Investors 5.70 36.38
02-09 13G/A Capital International Investors 10.50 3.13
01-29 13G/A BlackRock Inc. 6.10 -12.73

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-23 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SE
2023-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 Or ☐ TRANSITION REPORT PURSU
2023-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 Or ☐ TRANSITION REPORT PURSUANT T
2023-05-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 Or ☐ TRANSITION REPORT PURSUANT

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-17 88,144 305,301 28.87
2024-04-16 150,397 672,010 22.38
2024-04-15 174,843 815,301 21.45
2024-04-12 109,856 169,600 64.77

(click for more detail)

Similar Companies
ALB – Albemarle Corporation ASIX – AdvanSix Inc.
AVNT – Avient Corporation DD – DuPont de Nemours, Inc.
DNMR – Danimer Scientific, Inc.


Financial data and stock pages provided by
Fintel.io

Finpedia: Celanese Corporation